Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Agreement table at the mutation specific level

From: Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples

Idylla™ G12A G12C G12D G12R G12S G12V G13D No mutation detected Invalid A59E/P/V Q61H/H2 Q61K/K2 Q61L/R K117N1/N2 A146T/V/0 Total
therascreen                 
12ALA 6        1a         7
12CYS   6             1   7
12ASP    25              25
12ARG     3             3
12SER      6 1 1          8
12VAL       15    1       1 17
13ASP        16          16
No mutation detected     1a   1a 3a 97   1 3    2 4 112
Invalid/Run Control failed   2 1   3 2 1 41 6       1 57
Total 6 8 26 4 9 19 21 139 7 1 3 0 0 3 6 252
  1. Genotyping concordance between the Idylla™ test and the reference test. Italic: discordant by design specimens. a True discordant samples. Bold: mutant-mutant discordant results